comparemela.com
Home
Live Updates
Cidara Therapeutics to Present Ongoing Development of Drug-F
Cidara Therapeutics to Present Ongoing Development of Drug-F
Cidara Therapeutics to Present Ongoing Development of Drug-Fc Conjugates (DFC) Including CD73-Targeting DFC From Its Cloudbreak® Platform at Adenosine-Pathway Targeted Cancer Immunotherapy Summit
SAN DIEGO, June 20, 2023 -- Cidara Therapeutics, Inc. , a biotechnology company developing long-acting therapeutics designed to help improve the standard of care for patients facing serious... | June 20, 2023
Related Keywords
Boston ,
Massachusetts ,
United States ,
San Diego ,
California ,
Jeffrey Stein ,
James Levin ,
Veronica Eames ,
Cidara Cloudbreak ,
Brian Ritchie ,
Nasdaq ,
Preclinical Development ,
Securities Exchange ,
Cidara Therapeutics Inc ,
Lifesci Communications ,
Exchange Commission ,
Globenewswire Inc ,
Cidara Drug Fc Conjugates ,
Senior Director ,
Securities Act ,
Securities Exchange Act ,
Private Securities Litigation Reform Act ,
Quarterly Report ,